Create a Report
Please provide report title
Please provide location
Please provide details
Get alerts and updates for your case! Your contact information is not shown on the website.
This information is not shown on the website. We can notify you of updates, and may contact you for more information to help resolve or follow up on your issue.
Please provide email or phone
Please provide email or phone

We do not show your email or contact info

Please accept our Terms & Conditions
Add photos or video
We recommend photos and videos to help explain your report
Use camera
Select from library
Email or SMS copy of report
Enter below to get emailed a copy of your report, or sms a link to your report
Please provide email or phone
Please provide email or phone
Please accept our Terms & Conditions
Thank you for your report!


IMPORTANT - Your report is queued
It may take up to 12 hours to process your report.


Email us at support@safelyhq.com if you have questions.

Report by
Please provide location
Please provide location
Please provide report title
Please provide details
Please accept our Terms & Conditions
Get alerts and updates for your case! Your contact information is not shown on the website.

This information is not shown on the website. We can notify you of updates, and may contact you for more information to help resolve or follow up on your issue.

or
Please provide email or phone
Thank you for your report!

IMPORTANT - YOUR REPORT IS QUEUED - IT MAY TAKE UP TO 12 HOURS FOR YOUR REPORT TO SHOW ON OUR HOME PAGE (IF NOT OPTED AS PRIVATE)

If your report is poison related call 1-800-222-1222 for a free consultation with a live medical poisoning expert

Visit our learn pages for more helpful information or, email us: support@safelyhq.com

Goodbye! and best wishes in your recovery

Power Outage, Coarsegold, CA, USA

1 week ago

Coarsegold, 93614 California, United States

Pacific Gas & Electric is reporting multiple power outages affecting customers in and around Coarsegold.

1,061 customers are without power in Coarsegold. 1,131 customers without power between Reymon and Fresno Crossing. 1,475 customers are without power in Yosemite Lake.

Outage link: pgealerts.alerts.pge.com
Source: yourcentralvalley.com
Source publication date: 2021 09 09

Related Reports

Around 11,061 East Texans are currently without power in the following areas:

645 near Alba
2,284 near Grand Saline and Fruitvale
1,354 in Mineola
1,931 between Hoard and Hawkins
1,755 in Mt. Vernon
3,092 in Mt. Pleasant.

Source: ketk.com
Source publication date: 2021 09 20 See Less

Around 11,061 East Texans are currently without power in the following areas:

645 near Alba
2,284 near Grand Saline and Fruitvale
1,354 in Mineola
1,931 between Hoard and Hawkins
1,755 in Mt. Vernon
3,092 in Mt. Pleasant.

Source: ketk.com
Source publication date: 2021 09 20 See Less

Pacific Gas & Electric announced that a Public Safety Power Shutoff (PSPS) has been scheduled for Tuesday morning and will affect some residents in the Santa Ynez area.

The power shutoff is scheduled to begin at 7 a.m. on Tuesday, Sept. 21, ahead of dry, gusty winds... See More that were forecasted to occur.

PG&E said this shutoff will impact 19 PG&E serviced households and businesses located northeast of Santa Ynez and Highway 154 as well as along portions of Figueroa Road and Catway Road south to Mora Road.

More than 7,100 PG&E customers have been notified that a PSPS is going to occur.

Outage link: pgealerts.alerts.pge.com

Source: keyt.com
Source publication date: 2021 09 20
See Less

There are nearly 4,000 customers without power in Oakland, according to PG&E.

PG&E has said that the cause is likely weather-related.

Around 8:00 p.m., there were over 6,400 outages reported.

Source: kron4.com
Source publication date: 2021 09 20 See Less

Starting at 6 a.m. Monday, PG&E began shutting off power to sections of Tehama County due to weather conditions raising fire risk.

Around 1,450 customers in Gerber, Corning, Proberta and the foothills west of Red Bluff as well as Paskenta to the south Tehama County border went... See More without power for the Public Safety Power Shutoff event.

Outage link: pge.com

Source: redbluffdailynews.com
Source publication date: 2021 09 20
See Less

Starting at 6 a.m. Monday, PG&E began shutting off power to sections of Tehama County due to weather conditions raising fire risk.

Around 1,450 customers in Gerber, Corning, Proberta and the foothills west of Red Bluff as well as Paskenta to the south Tehama County border went... See More without power for the Public Safety Power Shutoff event.

Outage link: pge.com

Source: redbluffdailynews.com
Source publication date: 2021 09 20
See Less

Starting at 6 a.m. Monday, PG&E began shutting off power to sections of Tehama County due to weather conditions raising fire risk.

Around 1,450 customers in Gerber, Corning, Proberta and the foothills west of Red Bluff as well as Paskenta to the south Tehama County border went... See More without power for the Public Safety Power Shutoff event.

Outage link: pge.com

Source: redbluffdailynews.com
Source publication date: 2021 09 20
See Less

More than 800 Solano County residents are still without power as part of a planned Public Safety Power Shutoff by Pacific Gas & Electric that started early Monday morning.

Source: dailyrepublic.com
Source publication date: 2021 09 20 See Less

Around 6,000 residents remained without power across the Bay Area Sunday evening as PG&E worked to restore it following light overnight rain that triggered the outages

As of 7:30 p.m. Sunday, 6,003 remained without power: 5,749 in the East Bay; 12 in the Peninsula; 241 in San... See More Francisco; 1 in the South Bay.

Customers in the East Bay bore the brunt of the outages — initially with 23,800 people losing power in Richmond, El Cerrito, Moraga, Lafayette, Fremont, Hayward, San Leandro and Livermore.

In San Francisco, about 2,500 customers in the Bayview-Hunters Point lacked power on Sunday morning.

Source: sfchronicle.com
Source publication date: 2021 09 19
See Less

Around 6,000 residents remained without power across the Bay Area Sunday evening as PG&E worked to restore it following light overnight rain that triggered the outages

As of 7:30 p.m. Sunday, 6,003 remained without power: 5,749 in the East Bay; 12 in the Peninsula; 241 in San... See More Francisco; 1 in the South Bay.

Customers in the East Bay bore the brunt of the outages — initially with 23,800 people losing power in Richmond, El Cerrito, Moraga, Lafayette, Fremont, Hayward, San Leandro and Livermore.

In San Francisco, about 2,500 customers in the Bayview-Hunters Point lacked power on Sunday morning.

Source: sfchronicle.com
Source publication date: 2021 09 19
See Less

Recent Interesting Reports

Company name: Azurity Pharmaceuticals, Inc.
Brand name: Azurity
Product recalled: Firvanq
Reason of the recall: Product kit may contain incorrect diluent.
FDA Recall date: September 08, 2021
Recall details: Wilmington, MA, Azurity Pharmaceuticals, Inc. (“Azurity”) is voluntarily recalling one lot of Firvanq® (vancomycin hydrochloride for oral solution),... See More Vancomycin 50 mg/mL Kit (“Firvanq®”) to the consumer level, as some products in the affected lot have been found to incorrectly contain a First Omeprazole (FIRST-PPI) diluent instead of the Firvanq diluent bottle. To date, Azurity has not received any reports of adverse events related to this recall.

Risk Statement: Vancomycin may not be completely solubilized in the FIRST-PPI diluent which could lead to doses above or below those recommended in the label. There is reasonable probability that the administration of inappropriate doses of oral vancomycin may lead to persistent diarrhea associated with dehydration and electrolyte abnormalities, recurrence of Clostridium difficile (C. difficile) infection, its progression to severe colitis, colon perforation requiring colectomy, and potentially death. Especially, the elderly and immunocompromised patients are vulnerable to the complications of C. difficile infection.

Firvanq® is indicated for use in adults and pediatric patients less than 18 years of age for the treatment of: Clostridium difficile-associated diarrhea and Enterocolitis caused by Staphylococcus aureus (including methicillin-resistant strains).

The recalled product is packaged as a kit consisting of a bottle with Vancomycin Hydrochloride, USP powder, a bottle of Grape-Flavored diluent, and Full Prescribing Information. The product NDC is 65628-206-05 and the UPC code is 3 65628 206005 1. A total of 2,751 kits of the affected Firvanq®, lot number 21035, with an expiration date of 2022-07-31 were distributed. The product can be identified by its brand name Firvanq®.

This product was distributed nationwide through wholesale distributors. Azurity is notifying its distributors and customers by direct notifications to distributors and via this press release. Azurity is arranging for return and replacement of only recalled products. Consumers, distributors, and retailers that are in possession of Firvanq® from the affected lot should immediately stop using it and return it to the place of purchase. Distributors are asked to place any affected product under quarantine and return it promptly to Azurity.

Check the full recall details on fda.gov

Source: FDA
See Less

PetSmart, in cooperation with the Consumer Product Safety Commission (CPSC), announced a voluntary recall of more than 100,000 of the Top Paw® Double Diner Dog Bowl after learning of a potential risk of laceration if the gasket on the bottom of the product comes off, leaving an... See More unfinished edge. No other products are affected by this recall.

According to CPSC, PetSmart has received three reports of consumers receiving cuts and scratches after handling the bowls with the unfinished edge.

- Top Paw® Double Diner Dog Bowl. SKU: 5270098. UPC: 73725775404

The recalled product is described as a set of two elevated metal dog food bowls that sit in a metal base surrounded by a plastic gasket. The bowls were sold at the pet stores from October 2017 through June 2021.

The company advises consumers to immediately stop using the recalled product and to the nearest PetSmart for a full refund.

Source: petsmartcorporate.com
See Less

Company name: Pfizer
Brand name: CHANTIX
Product recalled: Varenicline tablets
Reason of the recall: N-nitroso-varenicline above acceptable daily intake level
FDA Recall date: September 16, 2021
Recall details: Pfizer is voluntarily recalling all lots of Chantix 0.5 mg and 1 mg Tablets to the patient (consumer/user) level... See More due to the presence of a nitrosamine, N-nitroso-varenicline, at or above the FDA interim acceptable intake limit. As alternative suppliers have been approved in the United States, Pfizer is undertaking this precautionary measure. Long-term ingestion of N-nitroso-varenicline may be associated with a theoretical potential increased cancer risk in humans, but there is no immediate risk to patients taking this medication. Check the link below for the full list of the recalled products.

The health benefits of stopping smoking outweigh the theoretical potential cancer risk from the nitrosamine impurity in varenicline. Nitrosamines are common in water and foods, including cured and grilled meats, dairy products and vegetables. Everyone is exposed to some level of nitrosamines. These impurities may increase the risk of cancer if people are exposed to them above acceptable levels over long periods of time.

Chantix is a treatment to help patients quit smoking and is intended for short-term use. People who smoke cigarettes are 15 to 30 times more likely to get lung cancer than people who do not smoke.

Smoking is also associated with many other cancers, as well as with cardiovascular disease and lung disease. CHANTIX has a safety profile that has been established over 15 years of marketing authorization and through a robust clinical program. Pfizer believes the benefit/risk profile of CHANTIX remains positive. Patients currently taking Chantix should consult with their healthcare provider about alternative treatment options.

To date, Pfizer has not received reports of adverse events assessed to be related to this recall. The NDC, Lot Number, Expiration Date, and Configuration details for Chantix Tablets are indicated in Appendix A. Photos of the products can be found in Appendix B.

The products were distributed nationwide to Wholesalers and Distributors in the United States, US Virgin Islands, and Puerto Rico from May 2019 to September 2021. Pfizer places the utmost emphasis on patient safety and product quality at every step in the manufacturing and supply chain process. Pfizer has notified their direct consignees by letter to arrange for return of any recalled product.

Wholesalers and Distributors with an existing inventory of Chantix tablets, should stop use and distribution and quarantine the product immediately. If you have further distributed the recalled product, please notify any accounts or additional locations which may have received the recalled product from you. Please conduct a sub-recall to those accounts and communicate this recall information immediately.

If you received free product through the Pfizer Patient Assistance Program (PAP) or the Pfizer Institutional Patient Assistance Program (IPAP), please check your stock immediately. Additionally, if you are aware of any patients to whom you dispensed the products and who still may have the product in their possession, please ask them to return the product.

As communicated by FDA, there is no immediate risk to patients taking Chantix.iv Patients who are taking this product should consult with their health care provider to determine if alternative treatments are available.

Check the full recall details on fda.gov

Source: FDA
See Less

Company name: ICU Medical, Inc.
Brand name: Hospira
Product recalled: Aminosyn II, 15%, An Amino Acid Injection, Sulfite
Reason of the recall: Presence of visible particulate matter
FDA Recall date: September 07, 2021
Recall details: ICU Medical, Inc. is voluntarily recalling one lot (2,112 units) of Aminosyn... See More II, 15%, An Amino Acid Injection, Sulfite Free intravenous (IV) solution to the hospital/user level due to the presence of visible particulate matter identified as fibers, hair, and proteinaceous material along with other particles. 

ICU Medical became aware of this issue while inspecting retain samples as part of routine process. Administration of a drug product that contains particulate matter could result in adverse events ranging from inflammation at the site of injection to more serious events that could include the formation of a blood clot obstructing the flow of blood which could lead to end-organ damage or death. 

To date, ICU Medical, Inc. has not received reports of adverse events or illnesses related to this recall. Aminosyn II, Sulfite-Free, (an amino acid injection) infused with dextrose by peripheral vein infusion is indicated as a source of nitrogen in the nutritional support of patients with adequate stores of body fat, in whom, for short periods of time, oral nutrition cannot be tolerated, is undesirable, or inadequate. 

Aminosyn II can be administered peripherally with dilute (5 to 10%) dextrose solution and I.V. fat emulsion as a source of nutritional support. This form of nutritional support can help to preserve protein and reduce the breakdown of organic or inorganic materials, such as proteins, sugars, fatty acids, etc. in stress conditions where oral intake is inadequate. Aminosyn II is also indicated for central vein infusion to prevent or reverse excreting more nitrogen than is being taken in in patients where the intestinal tract, by the oral, surgical opening into the stomach for the introduction of food or surgical procedure for a feeding tube routes cannot or should not be used and gastrointestinal absorption of protein is impaired. 

Product was distributed nationwide both by ICU Medical direct to customers and through medical distributors. The product is for human use only. ICU Medical acquired this product from Hospira, a Pfizer company; therefore, the affected product contains a Hospira NDC number and a Hospira label. The affected product lot, manufactured in the U.S. by ICU Medical in November 2020, is listed below:  

- Aminosyn® II 15% An Amino Acid Injection, Sulfite-Free. NDC: 0409-7171-17. Catalog Number: 07171-17. Lot Number: 4989094. Expiration Date: 01-Apr-2022. Configuration: Pharmacy Bulk. Package 2-liter. Flexible. Container. Manufacture Date: November 2020. Distribution Dates: January 2021 – March 2021.

ICU Medical is notifying its distributors and customers of this recall by letter and is arranging for the return of all recalled products.

Hospitals/distributors that have a product that is being recalled should stop use/further distribution and return to the place of purchase.

Customers with questions regarding this recall can call ICU Medical at 1-844-654-7780 Monday through Friday between the hours of 8 a.m. and 5 p.m. Central time. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to using these drug products.

Check the full recall details on fda.gov

Source: FDA
See Less

Company name: Top Quality Dog Food
Brand name: Top Quality Dog Food.com
Product recalled: Beef HVM
Reason of the recall: Potential Salmonella & Listeria monocytogenes contamination
FDA Recall date: August 26, 2021
Recall details: Top Quality Dog Food of Hyattsville, MD is recalling “Beef HVM” 1-pound packages... See More due to the potential of Salmonella spp., Listeria monocytogenes. Salmonella, Listeria, can affect animals eating the product and there is risk to humans handling contaminated products, especially if they have not thoroughly washed their hands after having contact with the products or any surfaces exposed to these products. Healthy people infected with Salmonella should monitor themselves for the following symptoms: nausea, vomiting, diarrhea or bloody diarrhea, abdominal cramping, and fever. Rarely, Salmonella can result in more serious ailments, including arterial infections, endocarditis, arthritis, muscle pain, eye irritation, and urinary tract symptoms.

Pets with Salmonella infections may be lethargic and have diarrhea or bloody diarrhea, fever, and vomiting. Some pets will have only decreased appetite, fever, and abdominal pain. Infected but otherwise healthy pets can be carriers and infect other animals or humans. If your pet has consumed the recalled product and has these symptoms, please contact your veterinarian. Listeria monocytogenes can cause serious and sometimes fatal infections in young children, vulnerable or elderly people, and others with compromised immune systems. Healthy people may suffer short-term symptoms such as fever, headaches, stiffness, abdominal pain, and diarrhea. Listeria monocytogenes infections pose a serious threat to pregnant woman, as it can lead to miscarriages and stillbirths. Listeria monocytogenes infections are uncommon in pets, but they are possible. Symptoms may include mild to severe diarrhea; anorexia; fever; nervous, muscular, and respiratory signs; abortion; depression; shock; and death. Healthy people should monitor themselves and their pets for symptoms.

The recalled “Beef HVM” was distributed in DC, MD, VA, DE, PA, MA, CT, and SC and product was distributed through mail order and direct delivery from 7/27/21 to 8/2/21. The “Beef HVM” comes in a 1-pound package marked with lot #071521 on the bottom right corner of the label.

No illnesses have been reported to date in connection with the “Beef HVM” 1-pound packages in question.

The contamination was noted after a state surveillance sample revealed the presence of Salmonella, Listeria monocytogenes, in some 1-pound. packages of Beef HVM. The remaining “Beef HVM” batch in our possession has been quarantined and we have discontinued the distribution of this batch while FDA and our company continue their investigation as to the source of the contamination. 

We encourage all customers who received this product to dispose of any unused product immediately. If you find the “Beef HVM” 1-pound package that shows the lot number: 071521 in your possession, we urge you to return it to the place of purchase for a full refund.

Check the full recall details on fda.gov

Source: FDA
See Less

Company name: Jacobus Pharmaceutical Company Inc.
Brand name: Ruzurgi®
Product recalled: Ruzurgi® (amifampridine) 10 mg tablets
Reason of the recall: Exceeds Specification for Total Yeast and Mold Counts
FDA Recall date: September 13, 2021
Recall details: Plainsboro, New Jersey, Jacobus Pharmaceutical Company Inc. is voluntarily recalling 3... See More lots of Ruzurgi® (amifampridine) 10 mg tablets to the consumer level. The products have been found to be contaminated with yeast, mold, and aerobic bacteria based on laboratory test results.

Oral products heavily contaminated with yeast, mold, and aerobic bacteria may result in serious and life-threatening infections. The use of the defective product in patients with underlying immunosuppressive conditions such as Lambert Eaton Syndrome (LEMS) increases the concern for serious infections.

The product is used as a treatment for LEMS in patients ages 6 to less than 17 and is packaged in 100 count bottles (NDC: 49938-110-01). The affected Ruzurgi® (amifampridine) tablets lots include the following control numbers and expiration dates:
- Control Number 18038, Expiration 03/2023
- Control Number 18039, Expiration 03/2023
- Control Number 18079, Expiration 05/2023

The Control Number is located to the right of the bottle’s front panel below the D2 Barcode. Ruzurgi® (amifampridine) was distributed worldwide to specialty pharmacies and physicians.

Jacobus was informed of this issue by their Canadian partner that was conducting confirmatory full testing on Control Number 18038. Jacobus conducted an expanded investigation which identified Control Numbers 18039 and 18079.

- Control Number 18038 was distributed between 05/25/2021 – 08/26/2021 (Canada only)
- Control Number 18039 was distributed between 06/01/2021 – 08/10/2021
- Control Number 18079 was distributed between 08/10/2021 – 08/30/2021

Jacobus Pharmaceutical Company Inc is notifying its distributors and customers via regular mail and electronic mail and is arranging for the return of all recalled products.

Consumers that have Ruzurgi® (amifampridine) which is being recalled should stop using and return this product. Consumers with questions regarding this recall can contact Jacobus Pharmaceutical Company Inc. by phone at (609)799-8221 ext. 2120, Monday thru Friday from 9:00 AM to 5:00 PM Eastern Standard Time. This recall is being conducted with the knowledge of the U.S. Food and Drug Administration and other health authorities.

Check the full recall details on fda.gov

Source: FDA
See Less

I saw an ad on the internet for a mini chainsaw called rosespros.
I paid $25.99 for it in May.
They took my money but I've never recieved the saw.

I'm so tired of being scammed by these crooked companies that float around on the internet and... See More basically steal from people. I ordered from an ad that popped up when I was playing a game See Less

Scam Hahdi, CT, USA

2 weeks ago

I ordered the battery powered chain saw on May 9th and still have not received it. I would like my money back. Hahdiy
Not sure being it was so long ago See Less

A boiled water advisory surrounds our street while at the same time we experience very low water pressure especially on higher floors. See Less

The FSAI announced the recall of unauthorized novel CBD food supplements due to the presence of unsafe levels of delta‐9‐tetrahydrocannabinol (THC) based on the European Food Safety Authority (EFSA) acute reference dose.

The recalled products are:
- Jacob Hooy, 2.75%CBD+, 10 ml, Batch number: 060977-0302, Best before... See More date: Feb-2022.
- Greenway, CBD Hemp Oil, 10 ml, Batch number: CB60001, Best before date: 10/12/2022.
- The Hemp Company, CBD Oil Original, 10 ml, Batch number: 10-10-139, Best before date: 04/2022.

FSAI requested to distributors withdraw the product from the market, and Retailers remove the products from sale. Consumers should not purchase or consume any of the implicated batches of the unauthorized novel CBD food supplements.

For more recall details check on FSAI website: fsai.ie

Source: FSAI
See Less